High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis

Research output: Contribution to journalArticlepeer-review

Standard

Harvard

APA

Vancouver

Author

Bibtex

@article{06bba71c09b94fd38774536dda4e5981,
title = "High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis",
keywords = "anti-PD-1, anti-PD-L1, pembrolizumab, melanoma, immune-related adverse event, arthritis",
author = "Mark Ford and Ilfita Sahbudin and Andrew Filer and Neil Steven and Benjamin Fisher",
year = "2018",
month = aug,
day = "13",
doi = "10.1093/rheumatology/key234",
language = "English",
journal = "Rheumatology",
issn = "1462-0324",
publisher = "Oxford University Press",

}

RIS

TY - JOUR

T1 - High proportion of drug hypersensitivity reactions to sulfasalazine following its use in anti-PD-1 associated inflammatory arthritis

AU - Ford, Mark

AU - Sahbudin, Ilfita

AU - Filer, Andrew

AU - Steven, Neil

AU - Fisher, Benjamin

PY - 2018/8/13

Y1 - 2018/8/13

KW - anti-PD-1

KW - anti-PD-L1

KW - pembrolizumab

KW - melanoma

KW - immune-related adverse event

KW - arthritis

U2 - 10.1093/rheumatology/key234

DO - 10.1093/rheumatology/key234

M3 - Article

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

ER -